About US
Contact us
-
Improving Solubility for Pharmaceuticals & Biologics 2010In the current economic climate, there is more pressure than ever before to ensure that pharmaceutical and biopharmaceutical drug candidates are developed into target effective and profit-making drugs2010/6/21
-
New Data Presented From EMBLEM™ Study For Pipeline Drug Epratuzumab For Patients Suffering From Moderate To Severe Systemic Lupus ErythematosusTreatment differences were observed as early as week 8, with further improvement to week 12 Epratuzumab 600 mg weekly was associated with greater BILAG improvement than placebo in affected body sy2010/6/21
-
Sparta Systems Unveils TrackWise Software Version 8Sparta Systems., Inc., the maker of TrackWise® software and the market leader in enterprise quality and compliance management solutions, recently announced the general availability of Version 8 of2010/6/21
-
Lonza Introduces Applied Protein Services Preclinical Platform To Improve Biologic Development SuccessLonza, a leader in biopharmaceutical development services and contract manufacturing, is launching a new set of immunogenicity, stability and protein engineering services to benefit customers. The new2010/6/18
-
SFDA and the Ministry of Health jointly launch supervision and examination of vaccine supervisionIn order to enforce the quality supervision over the biological vaccines (hereinafter referred to as vaccines), improve the quality assurance in vaccine production, circulation and inoculation2010/6/18
-
Vision Inspection System Eliminated Human Limitations & Labor Costs For Polypropylene Pharmaceutical BottlesA leading maker of plastic bottles originally inspected its clarified polypropylene pharmaceutical bottles for aesthetic defects using human eyes. Adopting a machine vision inspection system eliminate2010/6/17
-
Multistage Nanovector System Provides Sustained Delivery of siRNA Cancer Therapeutic in MiceNew research by scientists at The University of Texas Health Science Center at Houston (UTHealth) and The University of Texas M.D. Anderson Cancer Center could make it easier for patients to u2010/6/17
-
Avista Capital Partners Commits $48.5 Million to OptiNose to Develop Nasal Delivery TechnologyAvista Capital Partners, a leading private equity firm, recently announced it has committed to invest $48.5 million in OptiNose, which has developed an innovative nasal drug delivery technolog2010/6/17
-
Multistage Nanovector System Provides Sustained Delivery of siRNA Cancer Therapeutic in MiceNew research by scientists at The University of Texas Health Science Center at Houston (UTHealth) and The University of Texas M.D. Anderson Cancer Center could make it easier for patients to u2010/6/13
-
BD Launches World's Smallest Pen NeedleBD (Becton, Dickinson and Company), a leading global medical technology company, recently announced the launch of BD Ultra-Fine Nano, the world's smallest pen needle. The BD Nano pen needle is2010/6/13